Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $9 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.21.
Market Cap
9T
Revenue
4.59T
Profits
199.05B
PE Ratio
45.21
Profit Margin
4.34%
Dividend Yield
0.39%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | -0.56% | 2,072,376 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 620.51B | 0.31% | 5,271,630 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 438.16B | -0.03% | 4,156,176 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 389.68B | 1.05% | 3,863,760 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 306.33B | 0.40% | 5,225,709 | 65.77B |
| 6 | NVS | Novartis AG | 280.73B | -0.44% | 1,177,386 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 261.67B | -1.25% | 4,666,070 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 218.94B | -0.40% | 7,420,428 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 196.41B | 0.28% | 1,168,781 | 45.20B |
| 10 | AMGN | Amgen Inc. | 194.54B | -0.81% | 2,057,170 | 37.22B |
| 11 | GILD | Gilead Sciences, Inc. | 163.14B | 1.21% | 5,131,079 | 29.74B |
| 12 | ABT | Abbott Laboratories | 160.44B | -1.94% | 11,755,469 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 144.19B | 0.08% | 1,801,217 | 10.58B |
| 14 | DHR | Danaher Corporation | 141.67B | 0.56% | 2,918,870 | 24.78B |
| 15 | PFE | Pfizer Inc. | 139.52B | 1.28% | 42,952,535 | 63.32B |
| 16 | CVS | CVS Health Corporation | 135.12B | 1.68% | 7,263,802 | 405.62B |
| 17 | SYK | Stryker Corporation | 127.06B | 0.51% | 2,217,384 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 121.89B | -1.06% | 1,152,455 | 12.22B |
| 19 | BMY | Bristol-Myers Squibb Company | 121.18B | 3.06% | 12,089,269 | 48.48B |
| 20 | MDT | Medtronic plc | 106.97B | -0.36% | 4,885,100 | 36.36B |
| 21 | SNY | Sanofi | 105.50B | 1.15% | 2,697,604 | 54.60B |
| 22 | GSK | GSK plc | 104.14B | -0.93% | 2,050,820 | 43.29B |
| 23 | MCK | McKesson Corporation | 95.10B | 0.78% | 618,703 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 92.33B | 2.15% | 1,244,979 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 86.68B | -3.90% | 2,336,001 | 76.39B |
| 26 | CI | The Cigna Group | 80.55B | 3.76% | 1,283,326 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.46B | -0.22% | 604,975 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 66.37B | -0.27% | 13,165,455 | 20.61B |
| 29 | COR | Cencora, Inc. | 59.56B | 0.89% | 1,353,843 | 328.68B |
| 30 | CAH | Cardinal Health, Inc. | 54.72B | -0.91% | 2,286,106 | 250.74B |
| 31 | ARGX | argenx SE | 54.18B | -0.16% | 380,224 | 4.74B |
| 32 | MDLN | Medline Inc. | 53.31B | -1.12% | 3,540,666 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 52.85B | -0.46% | 3,250,607 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 51.76B | -0.42% | 2,565,845 | 28.34B |
| 35 | HUM | Humana Inc. | 48.74B | 3.51% | 1,156,927 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.51B | 0.11% | 522,943 | 4.45B |
| 37 | HLN | Haleon plc | 43.02B | 1.02% | 6,312,938 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 42.39B | 1.24% | 1,403,827 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 39.11B | -1.57% | 1,705,381 | - |
| 40 | NTRA | Natera, Inc. | 39.08B | 1.09% | 1,527,676 | 2.50B |
| 41 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.46B | -3.58% | 2,682,653 | 4.29B |
| 42 | A | Agilent Technologies, Inc. | 37.86B | -0.19% | 1,861,365 | 7.23B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 37.47B | -2.34% | 4,231,494 | 17.35B |
| 44 | WAT | Waters Corporation | 36.64B | -0.85% | 470,493 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.64B | -0.14% | 1,310,791 | 16.63B |
| 46 | ONC | BeOne Medicines AG | 33.79B | 1.76% | 459,224 | 5.74B |
| 47 | CNC | Centene Corporation | 33.72B | 1.40% | 2,782,043 | 178.33B |
| 48 | ALC | Alcon Inc. | 33.56B | 1.75% | 2,140,237 | 10.63B |
| 49 | RPRX | Royalty Pharma plc | 32.51B | 0.04% | 2,216,158 | 2.44B |
| 50 | VEEV | Veeva Systems Inc. | 31.97B | 3.52% | 1,857,264 | 3.32B |
| 51 | ZTS | Zoetis Inc. | 31.61B | -0.22% | 6,093,700 | 9.53B |
| 52 | BIIB | Biogen Inc. | 30.86B | 4.96% | 2,258,900 | 9.94B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 29.71B | 0.94% | 4,024,380 | 20.98B |
| 54 | DXCM | DexCom, Inc. | 29.46B | 1.85% | 3,553,942 | 4.82B |
| 55 | ILMN | Illumina, Inc. | 28.75B | -0.08% | 1,198,927 | 4.39B |
| 56 | RMD | ResMed Inc. | 28.63B | -2.63% | 2,161,421 | 5.54B |
| 57 | MRNA | Moderna, Inc. | 26.59B | -1.85% | 8,521,960 | 2.23B |
| 58 | MTD | Mettler-Toledo International Inc. | 26.26B | 0.26% | 99,357 | 4.09B |
| 59 | PHG | Koninklijke Philips N.V. | 26.15B | -0.22% | 655,677 | 20.34B |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.41B | 1.69% | 601,471 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.82B | -4.06% | 4,774,573 | 8.26M |
| 62 | INSM | Insmed Incorporated | 23.66B | -5.60% | 2,825,191 | 819.56M |
| 63 | DGX | Quest Diagnostics Incorporated | 22.95B | -0.04% | 568,852 | 11.28B |
| 64 | INCY | Incyte Corporation | 22.82B | -2.12% | 1,481,000 | 5.36B |
| 65 | BNTX | BioNTech SE | 22.78B | -1.55% | 671,434 | 3.23B |
| 66 | UTHR | United Therapeutics Corporation | 22.73B | -2.10% | 303,817 | 3.17B |
| 67 | LH | Labcorp Holdings Inc. | 22.69B | -0.05% | 396,268 | 14.14B |
| 68 | STE | STERIS plc | 21.15B | 0.49% | 526,009 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 21.00B | -1.03% | 1,776,021 | 1.08B |
| 70 | VTRS | Viatris Inc. | 19.09B | 0.74% | 5,786,837 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 18.20B | 3.00% | 2,724,808 | 8.41B |
| 72 | GMAB | Genmab A/S | 17.82B | -0.69% | 4,555,493 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.51B | -1.70% | 1,573,201 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 16.78B | -4.62% | 1,144,943 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 16.47B | -1.93% | 601,056 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.29B | -3.27% | 3,372,444 | 579.96M |
| 77 | MEDP | Medpace Holdings, Inc. | 15.14B | -1.49% | 261,760 | 2.68B |
| 78 | DVA | DaVita Inc. | 15.12B | 1.19% | 783,053 | 13.84B |
| 79 | JAZZ | Jazz Pharmaceuticals plc | 14.89B | -2.81% | 838,412 | 4.44B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.51B | -2.51% | 2,271,707 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.09B | -0.81% | 2,844,297 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.91B | 0.88% | 1,723,278 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.41B | 0.94% | 755,348 | 8.26B |
| 84 | SNN | Smith & Nephew plc | 13.02B | 1.24% | 1,673,539 | 6.16B |
| 85 | FMS | Fresenius Medical Care AG | 13.02B | 1.79% | 501,045 | 22.32B |
| 86 | ALGN | Align Technology, Inc. | 12.93B | 0.64% | 486,760 | 4.10B |
| 87 | ICLR | ICON Public Limited Company | 12.72B | -0.97% | 401,575 | 8.27B |
| 88 | MOH | Molina Healthcare, Inc. | 12.65B | 4.10% | 981,262 | 43.10B |
| 89 | ELAN | Elanco Animal Health Incorporated | 12.56B | 1.29% | 3,208,929 | 4.89B |
| 90 | PEN | Penumbra, Inc. | 12.54B | 0.26% | 379,201 | 1.45B |
| 91 | RVTY | Revvity, Inc. | 12.40B | -1.05% | 1,126,772 | 2.90B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.24B | -1.06% | 287,876 | 1.13B |
| 93 | SMMT | Summit Therapeutics Inc. | 11.88B | 0.33% | 3,389,953 | - |
| 94 | ABVX | ABIVAX Société Anonyme | 11.80B | -2.80% | 1,034,379 | 5.67M |
| 95 | AXSM | Axsome Therapeutics, Inc. | 11.75B | -2.36% | 762,430 | 708.24M |
| 96 | BAX | Baxter International Inc. | 11.66B | -0.22% | 8,519,502 | 11.32B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.44B | 0.14% | 1,587,086 | 3.24B |
| 98 | PODD | Insulet Corporation | 11.23B | 0.48% | 1,616,893 | 2.90B |
| 99 | CYTK | Cytokinetics, Incorporated | 11.17B | -3.10% | 1,891,495 | 105.82M |
| 100 | TECH | Bio-Techne Corporation | 11.12B | 0.08% | 2,176,689 | 1.21B |
| 101 | CRL | Charles River Laboratories International, Inc. | 11.07B | -1.57% | 910,133 | 4.03B |
| 102 | EHC | Encompass Health Corporation | 10.92B | -0.11% | 936,823 | 6.07B |
| 103 | GMED | Globus Medical, Inc. | 10.83B | 2.10% | 2,350,810 | 3.10B |
| 104 | RDY | Dr. Reddy's Laboratories Limited | 10.74B | -2.05% | 2,155,418 | 3.58B |
| 105 | KRYS | Krystal Biotech, Inc. | 10.71B | -0.65% | 378,785 | 417.30M |
| 106 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.44B | -3.00% | 2,481,755 | 622.01M |
| 107 | TEM | Tempus AI, Inc. | 10.04B | -3.95% | 4,139,228 | 1.36B |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.03B | 0.13% | 1,209,076 | - |
| 109 | NUVL | Nuvalent, Inc. | 9.83B | 0.03% | 2,458,548 | - |
| 110 | HSIC | Henry Schein, Inc. | 9.77B | 1.65% | 1,118,610 | 13.38B |
| 111 | ENSG | The Ensign Group, Inc. | 9.76B | -0.12% | 291,642 | 5.27B |
| 112 | OSCR | Oscar Health, Inc. | 9.52B | 3.47% | 3,839,247 | 13.30B |
| 113 | IONS | Ionis Pharmaceuticals, Inc. | 9.38B | -2.58% | 5,097,825 | 1.06B |
| 114 | UHS | Universal Health Services, Inc. | 9.25B | -1.80% | 607,349 | 17.76B |
| 115 | CORT | Corcept Therapeutics Incorporated | 9.22B | -6.51% | 1,325,306 | 769.10M |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.08B | -7.50% | 809,405 | 51.48M |
| 117 | HALO | Halozyme Therapeutics, Inc. | 9.03B | -0.12% | 1,822,524 | 1.51B |
| 118 | BRKR | Bruker Corporation | 8.98B | -1.81% | 1,752,294 | 3.46B |
| 119 | GKOS | Glaukos Corporation | 8.97B | - | 442,231 | 551.35M |
| 120 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.82B | 0.11% | 6,258,260 | 18.07M |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 8.77B | -3.21% | 237,397 | 7.46M |
| 122 | ALKS | Alkermes plc | 8.65B | -0.13% | 1,581,049 | 1.56B |
| 123 | QGEN | Qiagen N.V. | 8.57B | -0.17% | 2,970,462 | 2.10B |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.35B | -1.16% | 540,996 | 74.06M |
| 125 | SYRE | Spyre Therapeutics, Inc. | 8.24B | -4.10% | 1,038,819 | - |
| 126 | PCVX | Vaxcyte, Inc. | 8.23B | -2.03% | 831,065 | - |
| 127 | RGEN | Repligen Corporation | 8.17B | 0.44% | 753,304 | 763.34M |
| 128 | IBRX | ImmunityBio, Inc. | 8.16B | -5.23% | 9,894,898 | 140.98M |
| 129 | HQY | HealthEquity, Inc. | 8.00B | 1.33% | 939,392 | 1.34B |
| 130 | ATR | AptarGroup, Inc. | 7.97B | -0.51% | 391,605 | 3.87B |
| 131 | BIO | Bio-Rad Laboratories, Inc. | 7.96B | 0.50% | 339,946 | 2.59B |
| 132 | HIMS | Hims & Hers Health, Inc. | 7.96B | - | 9,410,577 | 2.37B |
| 133 | IMVT | Immunovant, Inc. | 7.95B | -2.54% | 806,418 | - |
| 134 | TGTX | TG Therapeutics, Inc. | 7.80B | -3.69% | 1,950,893 | 700.35M |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.37B | -0.84% | 420,774 | 217.17M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 7.26B | -2.53% | 600,989 | 569.61M |
| 137 | AVTR | Avantor, Inc. | 7.21B | 1.64% | 6,526,502 | 6.55B |
| 138 | HNGE | Hinge Health, Inc. | 6.96B | 1.35% | 2,478,108 | 646.34M |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.86B | -0.24% | 1,025,725 | 1.55B |
| 140 | PACS | PACS Group, Inc. | 6.85B | 0.12% | 630,762 | 5.43B |
| 141 | PTCT | PTC Therapeutics, Inc. | 6.75B | -4.15% | 984,879 | 827.11M |
| 142 | SRRK | Scholar Rock Holding Corporation | 6.55B | -3.54% | 1,675,568 | - |
| 143 | XENE | Xenon Pharmaceuticals Inc. | 6.55B | -1.74% | 1,527,395 | 7.50M |
| 144 | CHE | Chemed Corporation | 6.51B | 0.75% | 145,889 | 2.54B |
| 145 | COGT | Cogent Biosciences, Inc. | 6.40B | -3.63% | 1,610,082 | - |
| 146 | CGON | CG Oncology, Inc. | 6.39B | -3.64% | 992,417 | 5.07M |
| 147 | LQDA | Liquidia Corporation | 6.33B | -8.62% | 2,171,464 | 288.07M |
| 148 | GRFS | Grifols, S.A. | 6.15B | -0.96% | 545,748 | 8.58B |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.13B | -2.21% | 245,691 | 274.48M |
| 150 | TFX | Teleflex Incorporated | 6.04B | 0.49% | 359,368 | 2.13B |
| 151 | DFTX | Definium Therapeutics, Inc. | 5.79B | -7.27% | 1,799,832 | - |
| 152 | BLTE | Belite Bio, Inc | 5.78B | -1.54% | 194,553 | - |
| 153 | BLCO | Bausch + Lomb Corporation | 5.78B | -0.12% | 301,072 | 5.21B |
| 154 | BLLN | BillionToOne, Inc. | 5.67B | -2.78% | 594,157 | 354.54M |
| 155 | TWST | Twist Bioscience Corporation | 5.63B | -0.32% | 872,687 | 409.48M |
| 156 | ERAS | Erasca, Inc. | 5.57B | -3.40% | 2,555,112 | - |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.48B | 1.00% | 3,009,907 | 3.05B |
| 158 | STVN | Stevanato Group S.p.A. | 5.40B | 0.97% | 174,241 | 1.39B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.39B | 1.07% | 542,454 | 1.34M |
| 160 | TXG | 10x Genomics, Inc. | 5.30B | -2.25% | 2,496,885 | 638.78M |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.23B | -0.53% | 1,032,927 | 536.20M |
| 162 | SHC | Sotera Health Company | 5.18B | -1.36% | 2,941,657 | 1.19B |
| 163 | ORKA | Oruka Therapeutics, Inc. | 5.10B | -2.57% | 769,769 | - |
| 164 | CELC | Celcuity Inc. | 5.06B | -3.52% | 1,256,367 | - |
| 165 | CRSP | CRISPR Therapeutics AG | 4.99B | -5.10% | 1,965,020 | 4.10M |
| 166 | LEGN | Legend Biotech Corporation | 4.98B | -4.91% | 2,983,105 | 1.14B |
| 167 | RDNT | RadNet, Inc. | 4.98B | -3.49% | 577,431 | 2.14B |
| 168 | INDV | Indivior Pharmaceuticals, Inc. | 4.90B | -0.72% | 1,234,471 | 1.29B |
| 169 | CAI | Caris Life Sciences, Inc. | 4.82B | 0.41% | 4,267,049 | 907.29M |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.69B | -3.94% | 585,286 | 754.05M |
| 171 | MANE | Veradermics, Incorporated | 4.60B | -7.88% | 454,335 | - |
| 172 | VCYT | Veracyte, Inc. | 4.59B | 0.90% | 853,185 | 541.74M |
| 173 | LIVN | LivaNova PLC | 4.56B | 0.51% | 465,874 | 1.43B |
| 174 | MMED | MiniMed Group, Inc. | 4.52B | 5.30% | 1,411,664 | 3.10B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.44B | -9.12% | 1,037,510 | - |
| 176 | VKTX | Viking Therapeutics, Inc. | 4.43B | -1.90% | 2,006,679 | - |
| 177 | WAY | Waystar Holding Corp. | 4.42B | 2.67% | 1,896,800 | 1.16B |
| 178 | MMSI | Merit Medical Systems, Inc. | 4.37B | -0.25% | 800,714 | 1.54B |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 4.37B | -2.75% | 1,562,769 | 1.10B |
| 180 | NVST | Envista Holdings Corporation | 4.27B | 1.20% | 2,773,765 | 2.81B |
| 181 | LFST | LifeStance Health Group, Inc. | 4.22B | 1.59% | 2,410,777 | 1.49B |
| 182 | ALHC | Alignment Healthcare, Inc. | 4.21B | 2.77% | 1,927,231 | 4.26B |
| 183 | DNLI | Denali Therapeutics Inc. | 4.20B | 3.12% | 1,894,426 | - |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.10B | -8.69% | 2,503,163 | 56.99M |
| 185 | RLAY | Relay Therapeutics, Inc. | 4.08B | -6.40% | 2,370,921 | 10.68M |
| 186 | DOCS | Doximity, Inc. | 4.08B | 2.39% | 2,087,530 | 644.86M |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 4.02B | -0.51% | 696,411 | 2.23B |
| 188 | ICUI | ICU Medical, Inc. | 3.94B | 2.06% | 155,802 | 2.16B |
| 189 | DYN | Dyne Therapeutics, Inc. | 3.91B | 0.94% | 1,884,700 | - |
| 190 | IRTC | iRhythm Holdings, Inc. | 3.90B | 2.20% | 617,062 | 787.85M |
| 191 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | -5.62% | 486,050 | 22.57M |
| 192 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.03% | 3,385,986 | 596.96M |
| 193 | PBLS | Parabilis Medicines, Inc. | 3.77B | -3.07% | 640,727 | - |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.77B | -1.53% | 139,360 | 803.79M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.67B | -3.22% | 541,287 | - |
| 196 | ALMS | Alumis Inc. | 3.58B | -0.74% | 1,207,065 | 8.40M |
| 197 | ELVN | Enliven Therapeutics, Inc. | 3.55B | -0.43% | 600,100 | - |
| 198 | OGN | Organon & Co. | 3.55B | -0.15% | 1,616,544 | 6.16B |
| 199 | RCUS | Arcus Biosciences, Inc. | 3.53B | -2.94% | 954,764 | 236.00M |
| 200 | PRVA | Privia Health Group, Inc. | 3.51B | 1.46% | 1,045,403 | 2.25B |
| 201 | HAE | Haemonetics Corporation | 3.49B | 0.92% | 691,162 | 1.33B |
| 202 | BKD | Brookdale Senior Living Inc. | 3.44B | -0.07% | 4,744,381 | 3.00B |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 3.44B | -2.27% | 653,425 | 225.27M |
| 204 | OPCH | Option Care Health, Inc. | 3.41B | 0.60% | 1,738,824 | 5.67B |
| 205 | ARQT | Arcutis Biotherapeutics, Inc. | 3.39B | -2.24% | 1,439,069 | 415.62M |
| 206 | ADPT | Adaptive Biotechnologies Corporation | 3.36B | -0.19% | 1,844,673 | 295.41M |
| 207 | WRBY | Warby Parker Inc. | 3.36B | -5.65% | 2,545,182 | 890.57M |
| 208 | ITGR | Integer Holdings Corporation | 3.27B | 2.88% | 440,000 | 1.86B |
| 209 | RARE | Ultragenyx Pharmaceutical Inc. | 3.26B | -1.77% | 1,394,253 | 670.00M |
| 210 | NHC | National HealthCare Corporation | 3.25B | -1.19% | 116,972 | 1.53B |
| 211 | BEAM | Beam Therapeutics Inc. | 3.09B | -5.14% | 2,862,285 | 164.01M |
| 212 | GRAL | GRAIL, Inc. | 3.08B | -0.28% | 367,120 | 156.12M |
| 213 | CLDX | Celldex Therapeutics, Inc. | 3.02B | -1.48% | 660,161 | 865.00K |
| 214 | VERA | Vera Therapeutics, Inc. | 2.98B | -1.19% | 2,233,823 | - |
| 215 | IRON | Disc Medicine, Inc. | 2.90B | -0.80% | 496,296 | - |
| 216 | MBX | MBX Biosciences, Inc. | 2.86B | -1.65% | 643,341 | - |
| 217 | QURE | uniQure N.V. | 2.83B | -3.59% | 1,460,098 | 18.09M |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.81B | -2.30% | 2,546,806 | 3.37B |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.75B | -2.29% | 685,243 | 776.83M |
| 220 | TMDX | TransMedics Group, Inc. | 2.62B | 6.33% | 1,352,191 | 635.89M |
| 221 | KLRA | Kailera Therapeutics, Inc. | 2.59B | -3.43% | 525,349 | - |
| 222 | ESTA | Establishment Labs Holdings Inc. | 2.59B | -0.15% | 299,807 | 229.58M |
| 223 | IMNM | Immunome, Inc. | 2.58B | -2.36% | 986,512 | 4.02M |
| 224 | KOD | Kodiak Sciences Inc. | 2.57B | -0.51% | 570,314 | - |
| 225 | XRAY | DENTSPLY SIRONA Inc. | 2.56B | 4.24% | 5,763,930 | 3.68B |
| 226 | TARS | Tarsus Pharmaceuticals, Inc. | 2.55B | 2.01% | 1,113,208 | 535.08M |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.55B | -1.64% | 259,055 | 1.46B |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.52B | -5.17% | 3,147,935 | 885.72M |
| 229 | PGNY | Progyny, Inc. | 2.51B | 4.34% | 1,162,609 | 1.29B |
| 230 | RGC | Regencell Bioscience Holdings Limited | 2.50B | -14.12% | 476,169 | - |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.48B | -1.10% | 5,171,561 | - |
| 232 | PHVS | Pharvaris N.V. | 2.45B | - | 286,655 | - |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.43B | -2.78% | 830,820 | - |
| 234 | VCEL | Vericel Corporation | 2.43B | 1.04% | 432,209 | 292.09M |
| 235 | AGIO | Agios Pharmaceuticals, Inc. | 2.41B | -1.65% | 713,874 | 66.05M |
| 236 | CLOV | Clover Health Investments, Corp. | 2.41B | 2.93% | 4,808,004 | 2.21B |
| 237 | ASTH | Astrana Health, Inc. | 2.36B | 1.62% | 354,623 | 3.53B |
| 238 | NRIX | Nurix Therapeutics, Inc. | 2.36B | -1.52% | 1,550,879 | 36.77M |
| 239 | TRVI | Trevi Therapeutics, Inc. | 2.35B | -7.40% | 4,238,955 | - |
| 240 | PBH | Prestige Consumer Healthcare Inc. | 2.31B | -0.14% | 414,632 | 1.09B |
| 241 | NKTR | Nektar Therapeutics | 2.31B | -2.90% | 707,295 | 55.63M |
| 242 | LMAT | LeMaitre Vascular, Inc. | 2.29B | -2.38% | 409,950 | 256.28M |
| 243 | BHVN | Biohaven Ltd. | 2.28B | -2.44% | 1,690,911 | - |
| 244 | HTFL | HeartFlow, Inc. | 2.26B | -2.10% | 1,075,516 | 191.42M |
| 245 | ZLAB | Zai Lab Limited | 2.20B | -4.25% | 1,459,022 | 453.28M |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.16B | -3.14% | 1,437,607 | 52.04M |
| 247 | OMCL | Omnicell, Inc. | 2.12B | 3.92% | 587,740 | 1.23B |
| 248 | BFLY | Butterfly Network, Inc. | 2.12B | 1.50% | 7,969,417 | 102.92M |
| 249 | MESO | Mesoblast Limited | 2.11B | 5.05% | 342,604 | 65.38M |
| 250 | AVAH | Aveanna Healthcare Holdings Inc. | 2.11B | -0.31% | 1,907,358 | 2.52B |
| 251 | KARD | Kardigan, Inc. | 2.10B | -4.50% | 423,062 | - |
| 252 | NEOG | Neogen Corporation | 2.10B | 0.31% | 1,455,337 | 870.56M |
| 253 | AXGN | Axogen, Inc. | 2.10B | -2.69% | 1,001,064 | 238.11M |
| 254 | VRDN | Viridian Therapeutics, Inc. | 2.10B | -3.80% | 1,198,571 | 70.92M |
| 255 | MD | Pediatrix Medical Group, Inc. | 2.10B | -0.49% | 695,069 | 1.93B |
| 256 | PVLA | Palvella Therapeutics, Inc. | 2.09B | 0.88% | 209,774 | - |
| 257 | ADMA | ADMA Biologics, Inc. | 2.08B | -1.21% | 2,874,364 | 509.86M |
| 258 | SGRY | Surgery Partners, Inc. | 2.07B | -2.56% | 1,217,008 | 3.34B |
| 259 | ANAB | AnaptysBio, Inc. | 2.07B | 5.15% | 840,523 | 232.39M |
| 260 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.58% | 1,322,454 | 298.30M |
| 261 | HRMY | Harmony Biosciences Holdings, Inc. | 2.06B | -3.53% | 555,404 | 899.11M |
| 262 | SNDX | Syndax Pharmaceuticals, Inc. | 2.03B | -3.05% | 1,422,906 | 217.17M |
| 263 | NBTX | Nanobiotix S.A. | 2.02B | -2.30% | 106,906 | 38.27M |
| 264 | NUVB | Nuvation Bio Inc. | 2.01B | -0.69% | 4,095,038 | 143.05M |
| 265 | ABCL | AbCellera Biologics Inc. | 1.99B | -4.12% | 4,059,690 | 79.21M |
| 266 | ADUS | Addus HomeCare Corporation | 1.99B | 0.60% | 201,702 | 1.45B |
| 267 | SRPT | Sarepta Therapeutics, Inc. | 1.99B | -0.69% | 2,457,686 | 2.18B |
| 268 | SION | Sionna Therapeutics, Inc. | 1.98B | -2.96% | 415,290 | - |
| 269 | LKFT | Lakefront Biotherapeutics NV | 1.98B | -1.55% | 152,754 | 1.20B |
| 270 | HCM | HUTCHMED (China) Limited | 1.97B | 0.63% | 38,352 | 548.51M |
| 271 | TYRA | Tyra Biosciences, Inc. | 1.94B | -0.24% | 642,100 | - |
| 272 | RAPP | Rapport Therapeutics, Inc. | 1.94B | -2.78% | 364,521 | 20.00M |
| 273 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.94B | -2.03% | 1,468,236 | -665.00K |
| 274 | AGL | agilon health, inc. | 1.93B | 0.87% | 305,418 | 5.82B |
| 275 | URGN | UroGen Pharma Ltd. | 1.92B | 2.46% | 577,222 | 140.49M |
| 276 | ALMR | Alamar Biosciences, Inc. | 1.90B | -3.59% | 402,361 | 87.16M |
| 277 | WGS | GeneDx Holdings Corp. | 1.90B | -2.73% | 475,222 | 442.68M |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.88B | -0.52% | 520,169 | 367.34M |
| 279 | NVCR | NovoCure Limited | 1.86B | -1.29% | 857,420 | 674.41M |
| 280 | GLUE | Monte Rosa Therapeutics, Inc. | 1.86B | -4.60% | 1,586,837 | 42.95M |
| 281 | BCAX | Bicara Therapeutics Inc. | 1.85B | -2.63% | 420,314 | - |
| 282 | COAG | Hemab Therapeutics Holdings, Inc. | 1.85B | 3.89% | 369,987 | - |
| 283 | PGEN | Precigen, Inc. | 1.84B | -2.82% | 3,042,611 | 31.60M |
| 284 | NEO | NeoGenomics, Inc. | 1.84B | - | 1,543,181 | 745.97M |
| 285 | UFPT | UFP Technologies, Inc. | 1.84B | 0.14% | 217,166 | 608.85M |
| 286 | STOK | Stoke Therapeutics, Inc. | 1.83B | -6.12% | 580,457 | 32.08M |
| 287 | GENB | Generate Biomedicines, Inc. | 1.83B | -0.35% | 531,686 | 30.30M |
| 288 | ATAI | AtaiBeckley Inc. | 1.83B | -3.87% | 7,860,421 | 3.49M |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.82B | -8.44% | 7,478,707 | 66.09M |
| 290 | BHC | Bausch Health Companies Inc. | 1.81B | 1.46% | 1,598,084 | 10.53B |
| 291 | IOVA | Iovance Biotherapeutics, Inc. | 1.80B | -4.49% | 13,326,232 | 285.61M |
| 292 | PLSE | Pulse Biosciences, Inc. | 1.79B | -1.52% | 209,937 | 751.00K |
| 293 | ZYME | Zymeworks Inc. | 1.79B | -3.63% | 340,708 | 81.26M |
| 294 | CMPS | COMPASS Pathways plc | 1.78B | -3.34% | 3,033,289 | - |
| 295 | ATRC | AtriCure, Inc. | 1.76B | 1.52% | 501,316 | 552.16M |
| 296 | ZBIO | Zenas BioPharma, Inc. | 1.76B | -2.99% | 857,088 | 10.00M |
| 297 | AAPG | Ascentage Pharma Group International | 1.76B | -1.85% | 3,367 | 82.08M |
| 298 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -7.30% | 24,497,736 | 66.41M |
| 299 | TDOC | Teladoc Health, Inc. | 1.74B | 3.99% | 5,547,646 | 2.51B |
| 300 | GHRS | GH Research PLC | 1.74B | -4.38% | 196,029 | - |
| 301 | TRLV | Trulieve Cannabis Corp. | 1.74B | 4.87% | 939,880 | 1.17B |
| 302 | ABSI | Absci Corporation | 1.73B | -3.68% | 2,925,498 | 1.84M |
| 303 | DMRA | Damora Therapeutics, Inc. | 1.72B | -1.86% | 269,776 | - |
| 304 | TSHA | Taysha Gene Therapies, Inc. | 1.72B | -15.14% | 6,443,772 | 7.47M |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.72B | -1.21% | 303,397 | 923.71M |
| 306 | FTRE | Fortrea Holdings Inc. | 1.69B | 0.56% | 802,777 | 2.71B |
| 307 | MLTX | MoonLake Immunotherapeutics | 1.69B | 0.25% | 1,315,841 | - |
| 308 | MPLT | MapLight Therapeutics, Inc. | 1.66B | -6.99% | 511,492 | - |
| 309 | IMCR | Immunocore Holdings plc | 1.65B | 1.69% | 896,423 | 412.81M |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.65B | 1.05% | 504,905 | 1.85B |
| 311 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.64B | 4.43% | 3,145,795 | 204.73M |
| 312 | VIR | Vir Biotechnology, Inc. | 1.64B | -2.41% | 1,914,217 | 65.50M |
| 313 | INVA | Innoviva, Inc. | 1.64B | -0.13% | 592,234 | 420.69M |
| 314 | MAZE | Maze Therapeutics, Inc. | 1.61B | -4.55% | 508,262 | 20.00M |
| 315 | PSNL | Personalis, Inc. | 1.58B | 6.89% | 10,667,807 | 64.52M |
| 316 | AVBP | ArriVent BioPharma, Inc. | 1.57B | -0.15% | 327,924 | - |
| 317 | HROW | Harrow, Inc. | 1.56B | -1.58% | 289,282 | 268.68M |
| 318 | SEPN | Septerna, Inc. | 1.55B | -4.37% | 394,056 | 72.26M |
| 319 | INNV | InnovAge Holding Corp. | 1.53B | -2.17% | 288,457 | 949.17M |
| 320 | ENOV | Enovis Corporation | 1.51B | 1.94% | 914,620 | 2.28B |
| 321 | ATEC | Alphatec Holdings, Inc. | 1.50B | 1.67% | 1,794,254 | 787.08M |
| 322 | CDNA | CareDx, Inc. | 1.49B | 0.88% | 561,089 | 412.82M |
| 323 | INSP | Inspire Medical Systems, Inc. | 1.48B | -0.77% | 841,485 | 915.25M |
| 324 | NVAX | Novavax, Inc. | 1.47B | -4.50% | 3,855,077 | 596.34M |
| 325 | SVRA | Savara Inc. | 1.46B | -4.81% | 1,680,541 | - |
| 326 | IART | Integra LifeSciences Holdings Corporation | 1.45B | -1.12% | 803,304 | 1.64B |
| 327 | KMTS | Kestra Medical Technologies, Ltd. | 1.45B | -4.73% | 334,414 | 83.72M |
| 328 | ARDT | Ardent Health, Inc. | 1.44B | -0.10% | 437,325 | 6.43B |
| 329 | AKTS | Aktis Oncology, Inc. | 1.41B | -8.27% | 667,386 | 8.28M |
| 330 | XERS | Xeris Biopharma Holdings, Inc. | 1.41B | -2.16% | 1,471,881 | 314.85M |
| 331 | PRGO | Perrigo Company plc | 1.41B | -0.49% | 2,818,788 | 4.18B |
| 332 | OMDA | Omada Health, Inc. | 1.40B | 0.95% | 1,125,531 | 283.30M |
| 333 | PNTG | The Pennant Group, Inc. | 1.39B | -1.58% | 233,427 | 1.02B |
| 334 | STAA | STAAR Surgical Company | 1.38B | 0.07% | 752,600 | 290.38M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.37B | -0.28% | 484,389 | 101.66M |
| 336 | AHCO | AdaptHealth Corp. | 1.37B | 0.68% | 1,054,376 | 3.29B |
| 337 | INBX | Inhibrx Biosciences, Inc. | 1.35B | -0.91% | 233,313 | 1.30M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.34B | 2.90% | 498,170 | 1.50B |
| 339 | AMN | AMN Healthcare Services, Inc. | 1.32B | 4.97% | 1,182,509 | 3.42B |
| 340 | CNMD | CONMED Corporation | 1.28B | 10.21% | 2,454,469 | 1.37B |
| 341 | ARDX | Ardelyx, Inc. | 1.27B | -2.65% | 2,929,399 | 427.68M |
| 342 | AHG | Akso Health Group | 1.27B | -2.63% | 19,903 | 14.84M |
| 343 | JBIO | Jade Biosciences, Inc. | 1.26B | 1.67% | 1,587,732 | - |
| 344 | IMTX | Immatics N.V. | 1.26B | -4.65% | 178,908 | 43.00M |
| 345 | IRMD | IRADIMED CORPORATION | 1.25B | 0.50% | 136,390 | 86.28M |
| 346 | MNKD | MannKind Corporation | 1.25B | -1.22% | 4,043,844 | 360.78M |
| 347 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -6.13% | 1,485,152 | - |
| 348 | AVLN | Avalyn Pharma Inc. | 1.23B | -0.78% | 247,500 | - |
| 349 | NUTX | Nutex Health Inc. | 1.23B | -2.59% | 101,615 | 879.95M |
| 350 | SDGR | Schrödinger, Inc. | 1.23B | -0.49% | 782,158 | 254.91M |
| 351 | TRAX | First Tracks Biotherapeutics, Inc. | 1.22B | -3.39% | 965,823 | - |
| 352 | QDEL | QuidelOrtho Corporation | 1.22B | -2.08% | 1,122,791 | 2.66B |
| 353 | PRCT | PROCEPT BioRobotics Corporation | 1.21B | 1.58% | 1,084,814 | 322.02M |
| 354 | ALVO | Alvotech | 1.21B | 3.05% | 727,963 | 562.04M |
| 355 | AZTA | Azenta, Inc. | 1.20B | 2.72% | 575,247 | 596.48M |
| 356 | EYPT | EyePoint, Inc. | 1.20B | -2.99% | 962,578 | 7.61M |
| 357 | CAPR | Capricor Therapeutics, Inc. | 1.19B | -4.18% | 1,275,598 | 11.13M |
| 358 | AVNS | Avanos Medical, Inc. | 1.17B | - | 465,581 | 715.90M |
| 359 | AORT | Artivion, Inc. | 1.17B | -0.25% | 357,556 | 458.69M |
| 360 | WVE | Wave Life Sciences Ltd. | 1.14B | -4.80% | 2,411,085 | 71.80M |
| 361 | MGTX | MeiraGTx Holdings plc | 1.14B | -7.84% | 1,727,775 | 79.76M |
| 362 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | -1.16% | 343,215 | 796.33M |
| 363 | GMRS | GMR Solutions Inc. | 1.12B | -6.53% | 454,994 | 5.83B |
| 364 | TNDM | Tandem Diabetes Care, Inc. | 1.11B | 5.45% | 1,897,007 | 1.03B |
| 365 | XNCR | Xencor, Inc. | 1.11B | -5.62% | 662,541 | 97.36M |
| 366 | DRTS | Alpha Tau Medical Ltd. | 1.10B | -4.17% | 706,382 | - |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | -1.43% | 651,881 | - |
| 368 | SANA | Sana Biotechnology, Inc. | 1.09B | -5.45% | 2,467,739 | - |
| 369 | USPH | U.S. Physical Therapy, Inc. | 1.09B | -1.31% | 182,690 | 787.69M |
| 370 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | -3.59% | 888,917 | - |
| 371 | FBRX | Forte Biosciences, Inc. | 1.08B | 0.46% | 742,648 | - |
| 372 | SPTX | Seaport Therapeutics, Inc. | 1.08B | -6.86% | 63,234 | - |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.07B | -7.08% | 546,306 | 1.03B |
| 374 | CERT | Certara, Inc. | 1.06B | 0.30% | 1,973,426 | 419.75M |
| 375 | CRON | Cronos Group Inc. | 1.04B | - | 568,238 | 159.54M |
| 376 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | -0.50% | 1,226,607 | - |
| 377 | GDRX | GoodRx Holdings, Inc. | 1.03B | 3.05% | 857,780 | 787.89M |
| 378 | ETON | Eton Pharmaceuticals, Inc. | 1.02B | 1.99% | 270,603 | 86.93M |
| 379 | IVA | Inventiva S.A. | 1.01B | - | 735,102 | 7.94M |
| 380 | BVS | Bioventus Inc. | 1.01B | 1.60% | 657,497 | 576.30M |
| 381 | PCRX | Pacira BioSciences, Inc. | 1.00B | 0.24% | 450,606 | 734.86M |
| 382 | EVO | Evotec SE | 1.00B | -12.75% | 158,799 | 859.03M |
| 383 | AVTX | Avalo Therapeutics, Inc. | 994.01M | -1.56% | 698,842 | 59.00K |
| 384 | JANX | Janux Therapeutics, Inc. | 984.29M | -1.59% | 801,070 | 13.73M |
| 385 | ANRO | Alto Neuroscience, Inc. | 983.68M | 5.85% | 2,147,379 | - |
| 386 | VOR | Vor Biopharma Inc. | 976.97M | -5.80% | 1,107,755 | - |
| 387 | GLAS | Glass House Brands Inc. | 970.71M | -3.39% | 201,832 | 177.68M |
| 388 | KURA | Kura Oncology, Inc. | 968.53M | -4.72% | 1,579,693 | 71.64M |
| 389 | BIOA | BioAge Labs, Inc. | 968.40M | -10.50% | 548,811 | 10.32M |
| 390 | LXRX | Lexicon Pharmaceuticals, Inc. | 963.91M | -2.25% | 1,705,614 | 69.64M |
| 391 | SLDB | Solid Biosciences Inc. | 956.93M | -6.72% | 1,193,066 | - |
| 392 | PHAR | Pharming Group N.V. | 950.15M | -0.65% | 11,753 | 369.49M |
| 393 | DBVT | DBV Technologies S.A. | 948.71M | -3.09% | 129,643 | 5.74M |
| 394 | OPK | OPKO Health, Inc. | 928.76M | -8.89% | 5,062,486 | 581.12M |
| 395 | LBRX | LB Pharmaceuticals Inc | 924.82M | -2.12% | 135,228 | - |
| 396 | ANNX | Annexon, Inc. | 922.43M | -2.93% | 3,040,205 | - |
| 397 | ABUS | Arbutus Biopharma Corporation | 921.51M | -2.81% | 1,350,251 | 191.45M |
| 398 | AVR | Anteris Technologies Global Corp. | 911.12M | -4.20% | 690,592 | 1.85M |
| 399 | GERN | Geron Corporation | 910.96M | -5.33% | 7,162,276 | 196.12M |
| 400 | TALK | Talkspace, Inc. | 876.09M | - | 1,944,286 | 238.37M |
| 401 | TBPH | Theravance Biopharma, Inc. | 875.90M | -0.18% | 777,039 | 109.78M |
| 402 | INMD | InMode Ltd. | 870.83M | -0.85% | 693,073 | 374.64M |
| 403 | PHAT | Phathom Pharmaceuticals, Inc. | 866.98M | -13.44% | 1,837,439 | 204.89M |
| 404 | DSGN | Design Therapeutics, Inc. | 865.34M | -8.79% | 654,555 | - |
| 405 | FTH | Faeth Therapeutics, Inc. | 859.98M | -7.74% | 542,553 | - |
| 406 | AMPH | Amphastar Pharmaceuticals, Inc. | 850.55M | 3.04% | 384,539 | 720.53M |
| 407 | ODTX | Odyssey Therapeutics, Inc. | 843.13M | 5.51% | 330,309 | 1.06M |
| 408 | HSTM | HealthStream, Inc. | 839.06M | 2.28% | 171,566 | 311.78M |
| 409 | REPL | Replimune Group, Inc. | 834.00M | -9.60% | 2,829,991 | - |
| 410 | ESPR | Esperion Therapeutics, Inc. | 819.46M | - | - | 418.24M |
| 411 | TENX | Tenax Therapeutics, Inc. | 816.45M | -8.95% | 1,299,236 | - |
| 412 | CTMX | CytomX Therapeutics, Inc. | 805.50M | -1.60% | 3,314,274 | 35.54M |
| 413 | OCS | Oculis Holding AG | 794.10M | -3.52% | 302,549 | 1.40M |
| 414 | SIBN | SI-BONE, Inc. | 791.63M | 1.65% | 411,081 | 206.22M |
| 415 | ZVRA | Zevra Therapeutics, Inc. | 779.14M | -1.27% | 868,206 | 122.29M |
| 416 | AURA | Aura Biosciences, Inc. | 772.10M | 2.34% | 597,320 | - |
| 417 | SPRY | ARS Pharmaceuticals, Inc. | 768.61M | -2.52% | 1,399,972 | 98.99M |
| 418 | ACRS | Aclaris Therapeutics, Inc. | 768.15M | -1.43% | 1,087,870 | 8.37M |
| 419 | RIGL | Rigel Pharmaceuticals, Inc. | 764.14M | -2.94% | 430,633 | 299.77M |
| 420 | NGNE | Neurogene Inc. | 763.60M | -3.31% | 235,703 | 925.00K |
| 421 | CLYM | Climb Bio, Inc. | 756.41M | -5.64% | 1,235,984 | - |
| 422 | BBNX | Beta Bionics, Inc. | 755.32M | -0.47% | 1,015,548 | 110.24M |
| 423 | IMMX | Immix Biopharma, Inc. | 748.92M | -5.31% | 1,250,245 | - |
| 424 | CBLL | CeriBell, Inc. | 740.64M | -0.20% | 268,424 | 95.07M |
| 425 | DRUG | Bright Minds Biosciences Inc. | 730.11M | -2.45% | 389,928 | - |
| 426 | SSII | SS Innovations International, Inc. | 728.48M | -3.96% | 38,965 | 48.47M |
| 427 | OMER | Omeros Corporation | 724.48M | -2.63% | 1,220,291 | 9.89M |
| 428 | GYRE | Gyre Therapeutics, Inc. | 706.84M | -2.76% | 65,810 | 117.05M |
| 429 | CADL | Candel Therapeutics, Inc. | 706.33M | 1.58% | 1,627,536 | - |
| 430 | SLBT | SL Science Holding Limited | 699.84M | -8.46% | 36,945 | - |
| 431 | CSTL | Castle Biosciences, Inc. | 696.98M | -3.12% | 269,895 | 339.92M |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 693.02M | -5.82% | 2,268,681 | 361.51M |
| 433 | MNPR | Monopar Therapeutics Inc. | 692.18M | -3.07% | 214,641 | - |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 682.51M | 2.40% | 447,969 | - |
| 435 | PHR | Phreesia, Inc. | 681.79M | 2.89% | 1,005,295 | 495.59M |
| 436 | RLMD | Relmada Therapeutics, Inc. | 676.54M | 0.62% | 2,145,380 | - |
| 437 | ALLO | Allogene Therapeutics, Inc. | 666.15M | -3.50% | 8,941,782 | 22.00K |
| 438 | EVH | Evolent Health, Inc. | 665.89M | 0.68% | 1,645,663 | 1.89B |
| 439 | SGP | SpyGlass Pharma, Inc. | 665.32M | -11.63% | 221,478 | - |
| 440 | RGNX | REGENXBIO Inc. | 659.16M | -8.60% | 2,184,641 | 87.82M |
| 441 | TCMD | Tactile Systems Technology, Inc. | 655.03M | -2.65% | 268,367 | 343.52M |
| 442 | CRMD | CorMedix Inc. | 652.72M | -0.95% | 886,079 | 400.05M |
| 443 | TECX | Tectonic Therapeutic, Inc. | 647.97M | -0.09% | 150,120 | - |
| 444 | PRME | Prime Medicine, Inc. | 634.87M | -7.01% | 3,351,900 | 4.03M |
| 445 | ACHV | Achieve Life Sciences, Inc. | 626.22M | -0.16% | 1,327,459 | - |
| 446 | TOI | The Oncology Institute, Inc. | 624.89M | 6.11% | 3,018,618 | 545.76M |
| 447 | CERS | Cerus Corporation | 619.14M | -0.96% | 1,192,834 | 216.56M |
| 448 | MDXG | MiMedx Group, Inc. | 607.70M | -0.73% | 1,235,219 | 389.42M |
| 449 | AGMB | AgomAb Therapeutics NV | 606.24M | -5.89% | 116,204 | - |
| 450 | DNA | Ginkgo Bioworks Holdings, Inc. | 591.19M | -0.44% | 655,140 | 151.40M |
| 451 | FDMT | 4D Molecular Therapeutics, Inc. | 590.72M | -8.20% | 632,263 | 88.24M |
| 452 | NPCE | NeuroPace, Inc. | 583.68M | 0.06% | 97,375 | 99.53M |
| 453 | CTKB | Cytek Biosciences, Inc. | 582.43M | -2.38% | 1,140,189 | 204.17M |
| 454 | ALT | Altimmune, Inc. | 581.48M | -1.97% | 2,457,098 | 36.00K |
| 455 | NVCT | Nuvectis Pharma, Inc. | 581.33M | 0.49% | 175,460 | - |
| 456 | FLGT | Fulgent Genetics, Inc. | 579.94M | -0.63% | 319,597 | 320.35M |
| 457 | WEAV | Weave Communications, Inc. | 579.24M | 5.05% | 1,307,621 | 248.72M |
| 458 | BWAY | BrainsWay Ltd. | 567.55M | -6.37% | 115,015 | 56.22M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 565.21M | -1.32% | 191,150 | - |
| 460 | MYGN | Myriad Genetics, Inc. | 553.47M | 0.51% | 811,472 | 829.00M |
| 461 | CTNM | Contineum Therapeutics, Inc. | 546.59M | -3.75% | 261,009 | - |
| 462 | ASMB | Assembly Biosciences, Inc. | 534.27M | -1.61% | 112,993 | 71.10M |
| 463 | ANGO | AngioDynamics, Inc. | 532.49M | -0.12% | 436,384 | 313.73M |
| 464 | KIDS | OrthoPediatrics Corp. | 532.19M | 1.92% | 196,211 | 243.30M |
| 465 | TLRY | Tilray Brands, Inc. | 532.00M | 0.90% | 3,812,422 | 858.28M |
| 466 | ARVN | Arvinas, Inc. | 522.62M | -2.06% | 678,236 | 89.40M |
| 467 | CBIO | Crescent Biopharma, Inc. | 521.36M | -9.52% | 121,206 | 11.88M |
| 468 | AQST | Aquestive Therapeutics, Inc. | 509.40M | -1.46% | 1,624,047 | 50.27M |
| 469 | CTEV | Claritev Corporation | 508.71M | -4.48% | 97,058 | 978.76M |
| 470 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 471 | XOMA | XOMA Royalty Corporation | 503.77M | -9.16% | 6,711,917 | 48.56M |
| 472 | RZLT | Rezolute, Inc. | 495.17M | -0.21% | 2,446,462 | - |
| 473 | CLPT | ClearPoint Neuro, Inc. | 495.13M | -5.66% | 522,174 | 40.61M |
| 474 | STTK | Shattuck Labs, Inc. | 493.06M | -3.16% | 863,437 | 1.00M |
| 475 | NRC | NRC Health | 491.98M | 0.83% | 55,634 | 138.64M |
| 476 | VALN | Valneva SE | 490.82M | 4.16% | 18,127 | 180.25M |
| 477 | ZURA | Zura Bio Limited | 489.24M | 0.78% | 1,181,101 | - |
| 478 | PROK | ProKidney Corp. | 486.32M | -8.52% | 2,048,282 | 889.00K |
| 479 | EDIT | Editas Medicine, Inc. | 484.94M | -3.07% | 2,067,683 | 38.69M |
| 480 | SOPH | SOPHiA GENETICS SA | 479.88M | 1.24% | 230,517 | 81.18M |
| 481 | OCGN | Ocugen, Inc. | 477.32M | -4.08% | 5,548,395 | 4.47M |
| 482 | OFIX | Orthofix Medical Inc. | 476.57M | 1.38% | 269,370 | 825.37M |
| 483 | VMD | Viemed Healthcare, Inc. | 472.69M | 0.16% | 398,863 | 286.57M |
| 484 | KYTX | Kyverna Therapeutics, Inc. | 472.38M | -8.43% | 1,848,303 | - |
| 485 | VSTM | Verastem, Inc. | 471.88M | -2.89% | 2,416,670 | 49.59M |
| 486 | CYH | Community Health Systems, Inc. | 471.38M | -2.52% | 1,930,894 | 12.29B |
| 487 | SI | Shoulder Innovations, Inc. | 464.12M | 11.01% | 173,161 | 53.89M |
| 488 | PACB | Pacific Biosciences of California, Inc. | 462.80M | -4.49% | 5,397,032 | 160.03M |
| 489 | PRTA | Prothena Corporation plc | 462.28M | -4.44% | 781,723 | 57.94M |
| 490 | STRO | Sutro Biopharma, Inc. | 461.32M | -6.36% | 210,738 | 99.61M |
| 491 | VREX | Varex Imaging Corporation | 455.18M | -2.26% | 319,985 | 857.50M |
| 492 | OVID | Ovid Therapeutics Inc. | 453.54M | -3.57% | 995,932 | 7.12M |
| 493 | CABA | Cabaletta Bio, Inc. | 450.85M | -7.06% | 4,319,298 | - |
| 494 | BNTC | Benitec Biopharma Inc. | 446.26M | -3.20% | 85,501 | - |
| 495 | DCTH | Delcath Systems, Inc. | 444.29M | -1.08% | 388,997 | 90.44M |
| 496 | SGMT | Sagimet Biosciences Inc. | 441.53M | -2.99% | 917,544 | - |
| 497 | PRLD | Prelude Therapeutics Incorporated | 440.35M | -7.60% | 320,589 | 16.72M |
| 498 | SLN | Silence Therapeutics plc | 438.80M | 2.20% | 233,567 | 839.00K |
| 499 | NNNN | Anbio Biotechnology | 437.60M | 6.18% | 41,968 | 8.65M |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 437.08M | -3.74% | 189,886 | - |